Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2003;2003(5):299-307.
doi: 10.1155/S1110724303209268.

Optimization of Rolling-Circle Amplified Protein Microarrays for Multiplexed Protein Profiling

Optimization of Rolling-Circle Amplified Protein Microarrays for Multiplexed Protein Profiling

Weiping Shao et al. J Biomed Biotechnol. 2003.

Abstract

Protein microarray-based approaches are increasingly being used in research and clinical applications to either profile the expression of proteins or screen molecular interactions. The development of high-throughput, sensitive, convenient, and cost-effective formats for detecting proteins is a necessity for the effective advancement of understanding disease processes. In this paper, we describe the generation of highly multiplexed, antibody-based, specific, and sensitive protein microarrays coupled with rolling-circle signal amplification (RCA) technology. A total of 150 cytokines were simultaneously detected in an RCA sandwich immunoassay format. Greater than half of these proteins have detection sensitivities in the pg/ml range. The validation of antibody microarray with human serum indicated that RCA-based protein microarrays are a powerful tool for high-throughput analysis of protein expression and molecular diagnostics.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Schematic representation of microarray immunoassay with RCA signal amplification. It consists of (a) analyte capture by antibody immobilized on microarray, (b) detection by biotinylated secondary antibody, (c) binding of antibiotin antibody-oligonucleotide conjugate pre-annealed with circle 1, and (d) rolling-circle replication to generate long single-strand DNA which is hybridized with oligonucleotide decorator.
Figure 2
Figure 2
Optimization of antibodies from different sources (A and B) for choosing optimal pair for immunoassay on protein microarray with examples of (a) IL-13 and (b) MCP-2.
Figure 2
Figure 2
Optimization of antibodies from different sources (A and B) for choosing optimal pair for immunoassay on protein microarray with examples of (a) IL-13 and (b) MCP-2.
Figure 3
Figure 3
Titration of SSB in the RCA reaction mixtures. Cytokine IL-8 and Eot-2 at 100 pg/mL were detected.
Figure 4
Figure 4
Cross-reactivity of capture antibodies and analytes ((a) and (c)), capture antibodies and detection antibodies ((b) and (d)) on the subarrays 3 (A) and 4 (B). Each subarray was printed with about 35 different capture antibodies (listed on the chart). Cross-reactivity was determined by using different matched secondary antibody and 50 ng/mL or 0 ng/mL of its cognate analyte, which has been described in the text. A shaded square off the diagonal indicates the presence of nonspecific signals (intensity ≥ 300). None of these nonspecific signals exceed the intensity of 600 fluorescence intensity units (images are scanned at PMT of 600 and power of 100% on Axon scanner).
Figure 4
Figure 4
Cross-reactivity of capture antibodies and analytes ((a) and (c)), capture antibodies and detection antibodies ((b) and (d)) on the subarrays 3 (A) and 4 (B). Each subarray was printed with about 35 different capture antibodies (listed on the chart). Cross-reactivity was determined by using different matched secondary antibody and 50 ng/mL or 0 ng/mL of its cognate analyte, which has been described in the text. A shaded square off the diagonal indicates the presence of nonspecific signals (intensity ≥ 300). None of these nonspecific signals exceed the intensity of 600 fluorescence intensity units (images are scanned at PMT of 600 and power of 100% on Axon scanner).
Figure 5
Figure 5
Protein expression profiling of normal human serum (Sigma) on 70-feature antibody microarray. Specific signals detected were consistent with the protein level in serum. (a) Images of detecting 70 proteins in antibody microarray obtained with Axon microarray scanner. (b) Fluorescence intensities were derived from microarray images with averaging four spots of the same feature.
Figure 5
Figure 5
Protein expression profiling of normal human serum (Sigma) on 70-feature antibody microarray. Specific signals detected were consistent with the protein level in serum. (a) Images of detecting 70 proteins in antibody microarray obtained with Axon microarray scanner. (b) Fluorescence intensities were derived from microarray images with averaging four spots of the same feature.
Figure 5
Figure 5
Protein expression profiling of normal human serum (Sigma) on 70-feature antibody microarray. Specific signals detected were consistent with the protein level in serum. (a) Images of detecting 70 proteins in antibody microarray obtained with Axon microarray scanner. (b) Fluorescence intensities were derived from microarray images with averaging four spots of the same feature.

References

    1. MacBeath G, Schreiber S L. Printing proteins as microarrays for high-throughput function determination. Science. 2000;289(5485):1760–1763. - PubMed
    1. Zhu H, Bilgin M, Bangham R, et al. Global analysis of protein activities using proteome chips. Science. 2001;293(5537):2101–2105. - PubMed
    1. Haab B B, Dunham M J, Brown P O. Protein microarrays for highly parallel detection and quantitation of specific proteins and antibodies in complex solutions. Genome Biol. 2001;2(2):1–13. - PMC - PubMed
    1. Schweitzer B, Roberts S, Grimwade B, et al. Multiplexed protein profiling on microarrays by rolling-circle amplification. Nat Biotechnol. 2002;20(4):359–365. - PMC - PubMed
    1. Petricoin E F. 3rd, Ardekani A M, Hitt B A, et al. Use of proteomic patterns in serum to identify ovarian cancer. Lancet. 2002;359(9306):572–577. - PubMed

LinkOut - more resources